Published in Am J Trop Med Hyg on April 01, 1999
Incidence and risk factors for agranulocytosis in Latin American countries--the Latin Study: a multicenter study. Eur J Clin Pharmacol (2008) 0.84
Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012. Eur J Clin Pharmacol (2015) 0.81
Incidence of agranulocytosis in Southwest France. Eur J Epidemiol (2004) 0.75
Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases. Drugs Real World Outcomes (2016) 0.75
Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med (1995) 7.21
Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med (2000) 4.99
Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med (1994) 4.86
Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol (1992) 4.39
Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet (1996) 4.21
Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science (1993) 4.12
Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med (1989) 3.70
Tracking of blood lipids and blood pressures in school age children: the Muscatine study. Circulation (1978) 3.59
Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science (1998) 3.58
Brief report: transplantation of cord-blood stem cells into a patient with severe thalassemia. N Engl J Med (1995) 3.55
5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia. N Engl J Med (1982) 3.29
Oral-contraceptive use in relation to myocardial infarction. Lancet (1979) 3.04
A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature (1983) 3.02
Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med (1987) 2.93
Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement. Ann Intern Med (1972) 2.79
High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial. Lancet (2000) 2.75
Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Benedectin) in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol (1977) 2.65
The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med (1985) 2.64
An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediation. J Clin Invest (1972) 2.61
Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc Natl Acad Sci U S A (1991) 2.55
Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood (2000) 2.42
Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A (1985) 2.33
Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology (1996) 2.26
Bulk glasses and ultrahard nanoceramics based on alumina and rare-earth oxides. Nature (2004) 2.25
The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells. Cell (1991) 2.24
Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med (1999) 2.17
DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity. Cancer Res (1979) 2.08
Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest (1989) 2.08
Predictors of good function: the Framingham Study. J Chronic Dis (1987) 2.02
Coronary heart disease risk factors in school children: the Muscatine study. J Pediatr (1975) 2.02
Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc Natl Acad Sci U S A (2000) 2.00
Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. N Engl J Med (1999) 2.00
Hepatitis-associated aplastic anemia. N Engl J Med (1997) 1.98
Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet (1988) 1.97
Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein. Virology (1996) 1.97
Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins. J Virol (1999) 1.97
Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood (1995) 1.91
Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood (2001) 1.89
Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study. J Chronic Dis (1987) 1.86
Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med (1989) 1.85
Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc Natl Acad Sci U S A (1992) 1.82
Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC. J Clin Pathol (2000) 1.81
Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men. N Engl J Med (1983) 1.80
Characterization of a virus that causes transient aplastic crisis. J Clin Invest (1984) 1.78
Breast cancer before age 45 and oral contraceptive use: new findings. Am J Epidemiol (1989) 1.76
Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood (1992) 1.76
Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol (1993) 1.76
Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood (1994) 1.75
Cerebral abnormalities in myotonic dystrophy. Cerebral blood flow, magnetic resonance imaging, and neuropsychological tests. Arch Neurol (1993) 1.73
Prontosil in Erysipelas. Br Med J (1937) 1.70
Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines. Blood (1989) 1.69
Immunologic abnormalities in patients receiving multiple blood transfusions. Ann Intern Med (1984) 1.66
Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Nat Med (1995) 1.65
Breast cancer and oral contraceptive use. Am J Epidemiol (1984) 1.64
Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J Clin Invest (1992) 1.63
Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection. J Infect Dis (1997) 1.63
Relation of cigarette smoking to myocardial infarction in young women. N Engl J Med (1978) 1.62
Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results. J Natl Cancer Inst (1993) 1.59
Sulphanilamide in the Treatment of Erysipelas. Br Med J (1937) 1.56
Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia. Br J Haematol (1989) 1.56
Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood (1996) 1.56
Correction of the PNH defect by GPI-anchored protein transfer. Blood (1998) 1.55
Endometrial cancer and age at last delivery: evidence for an association. Am J Epidemiol (1991) 1.55
Low drug attributability of aplastic anemia in Thailand. The Aplastic Anemia Study Group. Blood (1997) 1.55
Prenatal and postnatal diagnoses of thalassemias and hemoglobinopathies by HPLC. Clin Chem (1998) 1.54
Risk factors for breast cancer. Am J Epidemiol (1983) 1.54
Genic variability and strategies of adaptation in animals. Proc Natl Acad Sci U S A (1973) 1.54
Pain and emotion: new research directions. J Clin Psychol (2001) 1.54
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. N Engl J Med (1978) 1.52
UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. Proc Natl Acad Sci U S A (1992) 1.52
Treatment of Diamond-Blackfan anaemia with haematopoietic growth factors, granulocyte-macrophage colony stimulating factor and interleukin 3: sustained remissions following IL-3. Br J Haematol (1991) 1.50
Evaluation of case reports of aplastic anemia among patients treated with felbamate. Epilepsia (1997) 1.49
A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus. J Virol (1992) 1.48
Genic heterozygosity in a population of Eutamias panamintinus. J Mammal (1973) 1.48
Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura. J Thromb Haemost (2012) 1.47
Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood (1999) 1.47
Dynamic imaging of the stomach by real-time ultrasound--a method for the study of gastric motility. Gut (1980) 1.46
Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med (1994) 1.45
Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol (1993) 1.45
Reliability of personal interview data in a hospital-based case-control study. Am J Epidemiol (1990) 1.43
Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med (1985) 1.43
Phase I study of repeated cycles of high-dose cyclophosphamide, etoposide, and cisplatin administered without bone marrow transplantation. J Clin Oncol (1990) 1.42
Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood (1986) 1.42
Short course training in epidemiology and biostatistics for graduate and undergraduate public health professionals. Public Health Rep (1994) 1.40
Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. N Engl J Med (1981) 1.39
Fanconi anemia and novel strategies for therapy. Blood (1994) 1.39
Cigarette smoking and age at natural menopause. Am J Public Health (1980) 1.39
Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest (1994) 1.39
The structure of human parvovirus B19 at 8 A resolution. Virology (1994) 1.38
Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro. J Immunol (1984) 1.38